← Back to headlines
Neurocrine to Acquire Soleno, Gaining Drug for Prader-Willi Syndrome
Neurocrine Biosciences announced its intent to acquire Soleno Therapeutics, thereby obtaining a drug designed to treat Prader-Willi syndrome, a disorder characterized by relentless hunger.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Philippines Announces Results of April 2026 Physicians Licensure Examination
just now
Pagasa flags 2 areas for dangerous heat index levels on April 9
just now
Philippines Experiences High Heat Index, DOH Issues Warnings as Areas Log Danger Levels
just now
Laguna Province Opens First Free Chemotherapy Center
just now